Here are some great reasons!
Now the general public can join investors from around the world and own shares in Tombot: a robotics company transforming the daily lives of families and communities facing health adversities
Taking away my mother's dog was among the most difficult decisions I've ever made. Diagnosed with Alzheimer's in 2011, my mother lost the ability to safely care for herself and her Goldendoodle companion.
Millions of people facing health adversities cannot safely or practically care for a live animal companion and therefore miss-out on the many mental and physical health benefits associated with the human-animal bond.
We launched Tombot in 2017 to serve these people.
97% of Seniors With Dementia suffer from behavioral and psychological symptoms of dementia (BPSD)1
83% of nursing home residents have Chronic Pain2
Tombot's go-to-market customer is a senior with dementia. 97% of Seniors With Dementia suffers from behavioral and psychological symptoms or dementia (BPSD) that include Depression, Delirium, Anxiety, Loneliness, Hallucinations and Violent Anger.
Real Puppy Sounds
Tombot makes realistic robotic animals designed to stimulate emotional attachment, at a price most people can afford. Peer-reviewed studies show that robotic animals positively affect some peoples' ability to cope with stress, anxiety, loneliness, depression, and pain, improving quality of life and redusing the need for certain medications.
Tombot is developing highly realistic and affordable robotic animal medical devices, and intends to files for FDA regulation
High GP revenue model: Multi-Billion Dollar Market
Relevant domain expertise with track record of success
Lead: Wavemaker 360 Health
IP granted and regulatory protection
Product Market Fit
Large customer studies and institutional research partners
We are seeking 5M to take us through first customer shipments
Seeking: $5 Series Seed Preferred / Previously closed $3.5M+ (Series Pre-seed, Seed I and Seed II)